Search

everythinglearnresearchcommunity

for

Search:↓

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Dental pulp stem cells might not reliably become neurons.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

Different medications can cause serious side effects in some people.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The FDA rejected a testosterone drug again due to safety concerns.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Dutasteride is approved to help manage prostate enlargement.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

The FDA did not approve a testosterone drug because of safety concerns.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Pranlukast and mirabegron may work as new diabetes drugs.

Upadacitinib improved multiple immune-related conditions in one patient.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Avacopan may cause unexpected side effects, so early monitoring is important.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Dutasteride may help reduce brain inflammation and improve cognition.

Dutasteride injections can help treat hair loss in men and women.